Cooler temperatures impair the immune system, enhancing the seasonal spread of cold virus
the ONA take:
Yale School of Medicine researchers investigated the association between colds and cold-weather seasons. Their results can help oncology nurses advise their patients on avoiding these illnesses in colder temperatures.
Scientists have known that the rhinovirus replicates most effectively in the nose for more than 50 years. The question is why. This study revealed that the rhinovirus, the most frequent cause of the common cold, reproduces more efficiently in colder weather.
In addition, lower temperatures reduce the immune system, making our bodies less adept at stopping the virus. The nose is the most vulnerable spot because it is 8° to 9° cooler than the rest of the body and breathing further exposes it to frigid winter air.
The researchers examined airway cells taken from mice and kept at 98.6° or 91.4°, the average temperature in our nostrils.
Both the enzymes that detect viruses and the signals that connect those sensors to the immune system worked more effectively in the warmer temperature. The researchers suspect that other viruses may take advantage of the general suppression of the immune system that occurs in cooler temperatures as well.
Wearing a scarf, which can create a pocket of warm air around the nose while outside, may be an effective measure patients can take to avoid the common cold.
Yale researchers investigated the association between colds and cold-weather seasons.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|